The estimated Net Worth of Stuart A Randle is at least $5.02 Million dollars as of 16 August 2024. Mr. Randle owns over 2,674 units of Teleflex stock worth over $1,997,810 and over the last 19 years he sold TFX stock worth over $2,759,047. In addition, he makes $262,458 as Independent Director at Teleflex.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Randle TFX stock SEC Form 4 insiders trading
Stuart has made over 24 trades of the Teleflex stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 2,674 units of TFX stock worth $323,554 on 16 August 2024.
The largest trade he's ever made was exercising 20,000 units of Teleflex stock on 17 September 2015 worth over $487,600. On average, Stuart trades about 1,918 units every 63 days since 2006. As of 16 August 2024 he still owns at least 8,170 units of Teleflex stock.
You can see the complete history of Mr. Randle stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stuart Randle biography
Stuart Allen Randle serves as Independent Director of the Company. Mr. Randle retired in December 2018 after serving for three years as the Chief Executive Officer of Ivenix, Inc., a medical device company that provides infusion delivery systems. Previously, Mr. Randle had been retired since September 2014 after serving for 10 years as President and Chief Executive Officer of GI Dynamics, Inc., a medical device company. From 2003 to 2004, he served as Interim Chief Executive Officer of Optobionics Corporation, a medical device company. From 2002 to 2003, Mr. Randle held the position of Entrepreneur in Residence of Advanced Technology Ventures, a healthcare and information technology venture capital firm. From 1998 to 2001, he was President and Chief Executive Officer of Act Medical, Inc. Prior to 1998, Mr. Randle held various senior management positions with Allegiance Healthcare Corporation and Baxter International Inc. Mr. Randle currently serves as a director of Beacon Roofing Supply, Inc.
What is the salary of Stuart Randle?
As the Independent Director of Teleflex, the total compensation of Stuart Randle at Teleflex is $262,458. There are 12 executives at Teleflex getting paid more, with Liam Kelly having the highest compensation of $6,782,760.
How old is Stuart Randle?
Stuart Randle is 60, he's been the Independent Director of Teleflex since 2009. There are 7 older and 11 younger executives at Teleflex. The oldest executive at Teleflex Incorporated is George Babich, 68, who is the Lead Independent Director.
What's Stuart Randle's mailing address?
Stuart's mailing address filed with the SEC is 550 E SWEDESFORD ROAD, SUITE 400, WAYNE, PA, 19087.
Insiders trading at Teleflex
Over the last 21 years, insiders at Teleflex have traded over $16,880,558 worth of Teleflex stock and bought 4,250 units worth $1,104,860 . The most active insiders traders include Gretchen R Haggerty, W Kim Foster, and Benson Smith. On average, Teleflex executives and independent directors trade stock every 22 days with the average trade being worth of $1,065,906. The most recent stock trade was executed by Stuart A Randle on 16 August 2024, trading 2,674 units of TFX stock currently worth $323,554.
What does Teleflex do?
teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. headquartered in wayne, pa, teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 150 countries.
What does Teleflex's logo look like?
Complete history of Mr. Randle stock trades at Beacon Roofing Supply Inc and Teleflex
Teleflex executives and stock owners
Teleflex executives and other stock owners filed with the SEC include:
-
Liam Kelly,
Chairman of the Board, President, Chief Executive Officer -
Thomas Powell,
Chief Financial Officer, Executive Vice President -
Liam J. Kelly,
Chairman, Pres & CEO -
James Leyden,
Corporate Vice President, General Counsel, Secretary -
Cameron Hicks,
Corporate Vice President - Human Resources and Communications -
Thomas E. Powell,
Exec. VP & CFO -
Karen Boylan,
Vice President - Global Strategic Projects -
James P. Winters,
Corp. VP, Manufacturing and Supply Chain -
Cameron P. Hicks,
Corp. VP & Chief HR Officer -
John Heinmiller,
Independent Director -
George Babich,
Lead Independent Director -
Candace Duncan,
Independent Director -
Stuart Randle,
Independent Director -
Andrew Krakauer,
Independent Director -
Gretchen Haggerty,
Independent Director -
Stephen Klasko,
Independent Director -
Richard Packer,
Independent Director -
James Winters,
Corporate Vice President - Manufacturing and Supply Chain -
Mario Wijker,
Corporate Vice President - QA/RA -
Jake Elguicze,
Treasurer and Vice President Investor Relations -
James Ferguson,
Pres & GM of Surgical -
Howard Cyr,
Corp. VP & Chief Compliance Officer -
Daniel V. Logue,
Corp. VP, Gen. Counsel & Sec. -
John Hsu C.F.A.,
VP of Investor Relations -
Timothy F. Duffy,
VP & Chief Information Officer -
John R. Deren,
Corp. VP & Chief Accounting Officer -
W Kim Foster,
Director -
Thomas Anthony Kennedy,
Senior VP, Global Operations -
Patricia C Barron,
Director -
Jeffrey A Graves,
Director -
William Roland Cook,
Director -
Benson Smith,
Director -
Richard A Meier,
Exec. Vice Pres. and CFO -
James W Zug,
Director -
Charles Edward Williams,
Corp. Controller and CAO -
John B Suddarth,
President-Aerospace -
Jeffrey P Black,
President, CEO -
Vincent Northfield,
President - Commercial -
R Ernest Waaser,
President - Medical -
Harold L Iii Yoh,
Director -
Sigismundus W W Lubsen,
Director -
Seldeneck Judith M Von,
Director -
Matthew J Jennings,
Sr. VP, Corp. Development -
Kevin K Gordon,
Vice Pres. Corporate -
Julie Mcdowell,
Sr. VP Corp. Communic. -
John J Sickler,
Vice Chairman -
Randall P Gaboriault,
Sr. Vice Pres. & Chf Info Off -
Laurence G Miller,
Sr.VP, General -
Forrest R Whittaker,
President - Medical -
James W Eug,
Director -
Steven Kent Chance,
Vice Pres., General -
James W Stratton,
Director -
Clark D Handy,
Exec.Vice Pres. -
Martin S Headley,
Exec. Vice Pres. -
Lennox K Black,
Non-Executive -
James V Agnello,
Corporate Controller -
Donald Beckman,
Director -
Joan W Schwartz,
Assoc.Gen'l Counsel -
Thomas M Byrne,
Assistant Treasurer -
Joseph S Gonnella,
Director -
C Jeffrey Jacobs,
Treasurer -
Harold L Jr Zuber,
Exec. Vice Pres. and -
Janine Dusossoit,
-
Jaewon Ryu,
Director -
Jay White,
CVP & Pres, Global Commercial -
John Deren,
Corp. VP & CAO -
Daniel V. Logue,
CVP, General Counsel & Secty -
Neena M Patil,
Director